Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments

[1]  O. Cussenot,et al.  The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol , 2022, Frontiers in Surgery.

[2]  I. Lawal,et al.  Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy , 2021, Journal of clinical medicine.

[3]  H. G. van der Poel,et al.  Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study. , 2021, Urologic oncology.

[4]  Yi Zhou,et al.  The characteristics and spatial distributions of prostate cancer in autopsy specimens , 2020, The Prostate.

[5]  A. Sidana,et al.  Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. , 2020, European urology.

[6]  P. Stricker,et al.  Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE) , 2020, World Journal of Urology.

[7]  N. Lawrentschuk,et al.  Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. , 2020, European urology.

[8]  H. Ahmed,et al.  A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer , 2020, Translational andrology and urology.

[9]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[10]  Ronald C. Chen,et al.  A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. , 2019, European urology oncology.

[11]  R. Karnes,et al.  Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review , 2019, World Journal of Urology.

[12]  M. Moerland,et al.  Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives , 2018, Cancers.

[13]  H. Sandler,et al.  Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial , 2018, JAMA oncology.

[14]  A. Cestari,et al.  Which technology to select for primary focal treatment of prostate cancer?—European Section of Urotechnology (ESUT) position statement , 2018, Prostate Cancer and Prostatic Diseases.

[15]  P. Scardino,et al.  Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens. , 2017, European Urology.

[16]  Mahul B Amin,et al.  Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2017, The American journal of surgical pathology.

[17]  Annie Gao,et al.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial , 2016, The Lancet. Oncology.

[18]  P. Gontero*,et al.  Changing the prostate cancer management pathway: why Focal Therapy is a step forward. , 2016, Archivos espanoles de urologia.

[19]  E. Barret,et al.  Focal Therapy for Prostate Cancer: An "À la Carte" Approach. , 2016, European urology.

[20]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[21]  Kirsten L. Greene,et al.  Patterns of Local Failure following Radiation Therapy for Prostate Cancer. , 2015, The Journal of urology.

[22]  Brett Delahunt,et al.  [International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. , 2013, Annales de pathologie.

[23]  P. Troncoso,et al.  Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. , 2012, The Journal of urology.

[24]  P. Scardino,et al.  Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. , 2012, European urology.

[25]  P. Carroll,et al.  Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. , 2012, International journal of radiation oncology, biology, physics.

[26]  J. Jones.  Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic. , 2011, European urology.

[27]  I. Tannock,et al.  Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. L. Cutajar,et al.  External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. , 2010, The Lancet. Oncology.

[29]  William C Huang,et al.  The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. , 2007, The Journal of urology.

[30]  Lars Egevad,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume , 2010, Modern Pathology.

[31]  G E Hanks,et al.  Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.